TY - JOUR
T1 - Cardiac resynchronisation therapy optimisation strategies
T2 - systematic classification, detailed analysis, minimum standards and a roadmap for development and testing
AU - Sohaib, S M Afzal
AU - Whinnett, Zachary I.
AU - Ellenbogen, Kenneth A.
AU - Stellbrink, Christoph
AU - Quinn, T Alexander
AU - Bogaard, Margot D.
AU - Bordachar, Pierre
AU - van Gelder, Berry M
AU - van Geldorp, Irene E
AU - Linde, Cecilia
AU - Meine, Mathias
AU - Prinzen, Frits W
AU - Turcott, Robert G
AU - Spotnitz, Henry M
AU - Wichterle, Dan
AU - Francis, Darrel P.
AU - International Working Group on Quantitative Optimization:
N1 - © 2013.
PY - 2013/12/10
Y1 - 2013/12/10
N2 - In this article an international group of CRT specialists presents a comprehensive classification system for present and future schemes for optimising CRT. This system is neutral to the measurement technology used, but focuses on little-discussed quantitative physiological requirements. We then present a rational roadmap for reliable cost-effective development and evaluation of schemes. A widely recommended approach for AV optimisation is to visually select the ideal pattern of transmitral Doppler flow. Alternatively, one could measure a variable (such as Doppler velocity time integral) and "pick the highest". More complex would be to make measurements across a range of settings and "fit a curve". In this report we provide clinicians with a critical approach to address any recommendations presented to them, as they may be many, indistinct and conflicting. We present a neutral scientific analysis of each scheme, and equip the reader with simple tools for critical evaluation. Optimisation protocols should deliver: (a) singularity, with only one region of optimality rather than several; (b) blinded test-retest reproducibility; (c) plausibility; (d) concordance between independent methods; and (e) transparency, with all steps open to scrutiny. This simple information is still not available for many optimisation schemes. Clinicians developing the habit of asking about each property in turn will find it easier to win now down the broad range of protocols currently promoted. Expectation of a sophisticated enquiry from the clinical community will encourage optimisation protocol-designers to focus on testing early (and cheaply) the basic properties that are vital for any chance of long term efficacy.
AB - In this article an international group of CRT specialists presents a comprehensive classification system for present and future schemes for optimising CRT. This system is neutral to the measurement technology used, but focuses on little-discussed quantitative physiological requirements. We then present a rational roadmap for reliable cost-effective development and evaluation of schemes. A widely recommended approach for AV optimisation is to visually select the ideal pattern of transmitral Doppler flow. Alternatively, one could measure a variable (such as Doppler velocity time integral) and "pick the highest". More complex would be to make measurements across a range of settings and "fit a curve". In this report we provide clinicians with a critical approach to address any recommendations presented to them, as they may be many, indistinct and conflicting. We present a neutral scientific analysis of each scheme, and equip the reader with simple tools for critical evaluation. Optimisation protocols should deliver: (a) singularity, with only one region of optimality rather than several; (b) blinded test-retest reproducibility; (c) plausibility; (d) concordance between independent methods; and (e) transparency, with all steps open to scrutiny. This simple information is still not available for many optimisation schemes. Clinicians developing the habit of asking about each property in turn will find it easier to win now down the broad range of protocols currently promoted. Expectation of a sophisticated enquiry from the clinical community will encourage optimisation protocol-designers to focus on testing early (and cheaply) the basic properties that are vital for any chance of long term efficacy.
KW - Cardiac Resynchronization Therapy
KW - Heart Conduction System
KW - Heart Failure
KW - Humans
KW - Models, Cardiovascular
KW - Reproducibility of Results
KW - Ultrasonography
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
KW - Review
U2 - 10.1016/j.ijcard.2013.10.069
DO - 10.1016/j.ijcard.2013.10.069
M3 - Article
C2 - 24239155
SN - 0167-5273
VL - 170
SP - 118
EP - 131
JO - International Journal of Cardiology
JF - International Journal of Cardiology
IS - 2
ER -